Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
4.580
-0.060 (-1.29%)
Nov 28, 2025, 1:00 PM EST - Market closed
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of $151.09 million as of November 28, 2025. Its market cap has increased by 31.50% in one year.
Market Cap
151.09M
Enterprise Value
135.27M
1-Year Change
31.50%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $151.09M, an increase of 81.60%. That is a compound annual growth rate of 2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 144.80M | 93.84% |
| Dec 31, 2024 | 74.70M | -38.06% |
| Dec 29, 2023 | 120.60M | -7.44% |
| Dec 30, 2022 | 130.30M | 46.40% |
| Dec 31, 2021 | 89.00M | 21.92% |
| Dec 31, 2020 | 73.00M | 10.11% |
| Dec 31, 2019 | 66.30M | -10.04% |
| Dec 31, 2018 | 73.70M | 106.44% |
| Dec 29, 2017 | 35.70M | -24.52% |
| Dec 30, 2016 | 47.30M | 79.85% |
| Dec 31, 2015 | 26.30M | 10.04% |
| Dec 31, 2014 | 23.90M | -39.34% |
| Dec 31, 2013 | 39.40M | 18.32% |
| Dec 31, 2012 | 33.30M | 73.44% |
| Dec 30, 2011 | 19.20M | -39.81% |
| Dec 31, 2010 | 31.90M | -65.14% |
| Dec 31, 2009 | 91.50M | 61.95% |
| Dec 31, 2008 | 56.50M | -63.00% |
| Dec 31, 2007 | 152.70M | 62.27% |
| Dec 29, 2006 | 94.10M | 31.24% |
| Dec 30, 2005 | 71.70M | -0.42% |
| Dec 31, 2004 | 72.00M | 94.07% |
| Dec 31, 2003 | 37.10M | 183.21% |
| Dec 31, 2002 | 13.10M | -52.88% |
| Dec 31, 2001 | 27.80M | -35.94% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |